Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Ritlecitinib is safe and may effectively treat alopecia areata.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

Alopecia areata may lead to hearing loss.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

IL-27 can prevent hair loss in alopecia areata.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Aloe Vera combined with i-PRF improves hair growth.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Alopecia areata causes hair loss and needs personalized care to manage its emotional and social effects.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

New research is helping develop better treatments for alopecia areata.

Certain genes are linked to the risk of developing Alopecia Areata.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Alopecia areata greatly affects quality of life, needing psychological support.

Hair loss in young men in Central India is linked to severe heart disease.

Ift20 is essential for hair follicle function and skin cell movement.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

The Turkish version of the Alopecia Areata Quality of Life Index is reliable and valid.

Adenosine may promote hair growth by increasing FGF-7 levels in dermal papilla cells.

A new treatment plan for alopecia areata considers disease severity, quality of life, and progression to offer personalized care.